Diabetes protection and restoration of thymocyte apoptosis in NOD Idd6 congenic strains

Diabetes

Volumn 52, Issue 7, 2003, Pages 1677-1682

  Bergman, Marie Louise ^a   Duarte, Nadia ^a,b   Campino, Susana ^b   Lundholm, Marie ^a   Motta, Vinicius ^a   Lejon, Kristina ^a   Penha Gonçalves, Carlos ^b   Holmberg, Dan ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SELECTION; DIABETES MELLITUS; DIABETOGENESIS; DISEASE RESISTANCE; FEMALE; GENE LOCUS; GENE MAPPING; HEREDITY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THYMOCYTE;

EID: 0038692172     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.7.1677     Document Type: Article

References (51)

1. Bottazzo GF, Todd I, Mirakian R, Belfiore A, Pujol-Borrell R: Organ-specific autoimmunity: a 1986 overview. Immunol Rev 94:137-169, 1986
2. Castano L, Eisenbarth GS: Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647-679, 1990
3. Delovitch TL, Singh B: The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727-738, 1997
4. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996
5. Ikegami H, Makino S: The NOD mouse and its related strains. In Animal Models of Diabetes: A Primer. Sima AAF, Shafrir E, Eds. Amsterdam, Harwood Academic Publishers, 2001, p. 43-61
6. Rogner UC, Boitard C, Morin J, Melanitou E, Avner P: Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains. Genomics 74:163-171, 2001
7. Serreze DV, Leiter EH: Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr Dir Autoimmun 4:31-67, 2001
8. Hill NJ, Lyons PA, Armitage N, Todd JA, Wicker LS, Peterson LB: NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 49:1744-1747, 2000
9. Lyons PA, Hancock WW, Denny P, Lord CJ, Hill NJ, Armitage N, Siegmund T, Todd JA, Phillips MS, Hess JF, Chen SL, Fischer PA, Peterson LB, Wicker LS: The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 13:107-115, 2000
10. Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, et al: The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231:733-735, 1986
11. Ikegami H, Makino S: Genetic susceptibility to insulin-dependent diabetes mellitus: from NOD mice to humans. In Lessons From Animal Diabetes. Shafrir E, Ed. London, Smith-Gordon, 1993, p. 39-50
12. Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y, Appel MC: Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 165:1639-1654, 1987
13. Denny P, Lord CJ, Hill NJ, Goy JV, Levy ER, Podolin PL, Peterson LB, Wicker LS, Todd JA, Lyons PA: Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 46:695-700, 1997
14. Grattan M, Mi QS, Meagher C, Delovitch TL: Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51:215-223, 2002
15. Babaya N, Ikegami H, Fujisawa T, Ueda H, Nojima K, Itoi-Babaya M, Yamada K, Kawaguchi Y, Yamato E, Makino S, Ogihara T: Sequence analysis of Tnf as a candidate for Idd16. Autoimmunity 35:63-66, 2002
16. Siegmund T, Armitage N, Wicker LS, Peterson LB, Todd JA, Lyons PA: Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes 49:1612-1616, 2000
17. Wicker LS, Todd JA, Peterson LB: Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13:179-200, 1995
18. Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL: IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 159:4686-4692, 1997
19. + T cell-defective IL-4 production in the non-obese diabetic mouse. Int Immunol 8:1751-1758, 1996
20. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL: Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:87-99, 1993
21. Rapoport MJ, Lazarus AH, Jaramillo A, Speck E, Delovitch TL: Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J Exp Med 177:1221-1226, 1993
22. Colucci F, Bergman ML, Penha-Goncalves C, Cilio CM, Holmberg D: Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci U S A 94:8670-8674, 1997
23. Kishimoto H, Sprent J: A defect in central tolerance in NOD mice. Nat Immunol 2:1025-1031, 2001
24. -/- mice display T cell apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice. J Autoimmun 16:105-113, 2001
25. Penha-Goncalves C, Leijon K, Persson L, Holmberg D: Type 1 diabetes and the control of dexamethazone-induced apoptosis in mice maps to the same region on chromosome 6. Genomics 28:398-404, 1995
26. Leijon K, Hammarstrom B, Holmberg D: Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol 6:339-345, 1994
27. Lander ES, Green P, Abrahamson J, Barlow A, Daly MJ, Lincoln SE, Newburg L: Mapmaker: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1:174-181, 1987
28. Paterson AH, Lander ES, Hewitt JD, Peterson S, Lincoln SE, Tanksley SD: Resolution of quantitative traits into Mendelian factors by using a complete linkage map of restriction fragment length polymorphisms. Nature 335:721-726, 1988
29. Lander ES, Botstein D: Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps [published erratum appears in Genetics 136:705, 1994]. Genetics 121:185-199, 1989
30. Ghosh S, Palmer SM, Rodrigues NR, Cordell HJ, Hearne CM, Cornall RJ, Prins JB, McShane P, Lathrop GM, Peterson LB, et al: Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet 4:404-409, 1993
31. Carnaud C, Gombert J, Donnars O, Garchon H, Herbelin A: Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J Immunol 166:2404-2411, 2001
32. King LB, Vacchio MS, Dixon K, Hunziker R, Margulies DH, Ashwell JD: A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 3:647-656, 1995
33. Sacedon R, Vicente A, Varas A, Jimenez E, Munoz JJ, Zapata AG: Role of glucocorticoids in early T-cell differentiation. Ann N Y Acad Sci 917:732-740, 2000
34. Vacchio MS, Lee JY, Ashwell JD: Thymus-derived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCR-mediated thymocyte activation. J Immunol 163:1327-1333, 1999
35. Ashwell JD, Vacchio MS, Galon J: Do glucocorticoids participate in thymocyte development? Immunol Today 21:644-646, 2000
36. Godfrey DI, Purton JF, Boyd RL, Cole TJ: Stress-free T-cell development: glucocorticoids are not obligatory. Immunol Today 21:606-611, 2000
37. Purton JF, Boyd RL, Cole TJ, Godfrey DI: Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 13:179-186, 2000
38. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100-103, 1994
39. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852, 1993
40. Geenen V, Kroemer G: Multiple ways to cellular immune tolerance. Immunol Today 14:573-575, 1993
41. Schwartz LM, Osborne BA: Programmed cell death, apoptosis and killer genes. Immunol Today 14:582-590, 1993
42. + T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med 188:415-420, 1998
43. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976, 1994
44. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992
45. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269, 1991
46. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547, 1995
47. Garchon HJ, Luan JJ, Eloy L, Bedossa P, Bach JF: Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur J Immunol 24:380-384, 1994
48. Bergman ML, Penha-Goncalves C, Lejon K, Holmberg D: Low rate of proliferation in immature thymocytes of the non-obese diabetic mouse maps to the Idd6 diabetes susceptibility region. Diabetologia 44:1054-1061, 2001
49. Evan G, Littlewood T: A matter of life and cell death. Science 281:1317-1322, 1998
50. Sakamuro D, Prendergast GC: New Myc-interacting proteins: a second Myc network emerges. Oncogene 18:2942-2954, 1999
51. Noorchashm H, Moore DJ, Noto LE, Noorchashm N, Reed AJ, Reed AL, Song HK, Mozaffari R, Jevnikar AM, Barker CF, Naji A: Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol 165:4685-4696, 2000